Aktis Oncology, Inc. company logo
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) Depreciation & Amortization

Annual D&A

N/A

Summary

Status
AKTS annual D&A is unknown

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AKTS Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A-
Quarterly D&A-
TTM D&A-
Price$19.64
Annual SG&A$12.58M+100.0%+146.4%+146.4%+146.4%
Annual Total Expenses-
Annual Operating Expenses-
Annual Revenue-

Depreciation & Amortization Highs

AKTS Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$445.00KN/AN/A
5Y$445.00KN/A
All$445.00KN/A

Depreciation & Amortization Lows

AKTS Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$445.00KN/AN/A
5Y$445.00KN/A
All$445.00KN/A

Depreciation & Amortization History

YearValueChange
$445.00K-

FAQ

  • What is the current annual D&A of AKTS?

    AKTS annual D&A is unknown

  • What is 1-year change in AKTS annual D&A?

    AKTS annual D&A 1-year change is unknown

  • What is 3-year change in AKTS annual D&A?

    AKTS annual D&A 3-year change is unknown

  • How far is AKTS annual D&A from its all-time high?

    AKTS annual D&A vs all-time high is unknown

  • When is AKTS next annual earnings release?

    The next annual earnings release for AKTS is on

Data Sources & References

  1. AKTS Official Website www.aktisoncology.com
  2. AKTS Profile on Yahoo Finance finance.yahoo.com/quote/AKTS
  3. AKTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akts